Sudeep Pharma’s Initial Public Offering to open on November 21, 2025
Sudeep Pharma has fixed the price band of ₹ 563- to ₹ 593 - per Equity Share of face value ₹1/- each for its maiden initial public…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Initial Public Offering
SPC Life Sciences files DRHP with SEBI
Equipped with a US FDA approved facility for 6-Chloro-Hexane-2-One, the company can develop pharma intermediates and work with…
Concord Biotech gets SEBI nod for IPO
The issue with a face value of Re 1 per equity share is a complete Offer For Sale (OFS) aggregating to 20,925,652 equity shares by…
Concord Biotech files DRHP for IPO
The issue with a face value of Re 1 per equity share is a complete Offer For Sale (OFS) aggregating to 20,925,652 equity shares by…
Innova Captab files DRHP to raise funds via IPO
The offer is being made through the book building process, wherein not more than 50 per cent of the offer shall be available for…
Macleod Pharma gets nod for IPO
The firm, which filed its preliminary IPO papers with Sebi between December 2021 and March 2022, obtained Sebi's observations…
Supriya Lifescience IPO to open on 16th December
The price band of the offer has been fixed at Rs 265 to Rs 274 per equity share. Bids can be made for a minimum of 54 equity…
Alkem Laboratories gets SEBI’s nod for IPO
As per the draft papers, the company will come out with a public offer of up to 12,853,442 equity shares
Syngene International IPO oversubscribed 31 times
The IPO is an offer for sale (OFS) by Biocon of a part of its shareholding in Syngene
Syngene International's (Syngene) Initial…
Biocon top line grows 15 per cent in Q4 FY15
Research services subsidiary Syngene delivers 27 per cent growth